In view of the tremendous amount of image data from 
DCE MRI, computer aided lesion detection and 
evaluation may be more helpful to decrease time of 
interpreting breast MRI, misdiagnosis due to the lack 
of experience and, more important to increase the 
diagnostic accuracy and sensitivity. 
  
In the first two years, we have used the 
characteristics extracted from kinetic curve and 
morphology of tumor to diagnose breast tumor 
respectively. Furthermore, we combined these two 
kinds of features to make up the drawbacks of using 
only one kind of features for improving diagnosis 
accuracy. In the third year project, there was 
development of an effective computer-aided breast MRI 
system for diagnosing lesion for evaluating their 
characters using the change of contrast agent and the 
morphology of breast tumor. 
 
During the past three years, several important 
results were obtained in this project, including (1) 
segmenting the breast tumor on MRI, (2) evaluating 
characteristics of kinetic curve and selecting the 
representative curve using fuzzy-C mean technique, 
(3) testing different methods of morphologic fitting 
in dynamic and contrast enhanced breast MRI, (4) 
Feature extraction and characterization of focal 
breast lesion, (5) enrolled patients from clinical 
track to increase our database, (6) combined kinetic 
and morphologic features for lesion characterization. 
Our preliminary results showed that an effective CAD 
system for breast MRI including kinetic and 
morphologic characterization can increase diagnostic 
efficacy. We will continue construct our imaging and 
CAD platform for breast MRI for clinical 
implementation. 
英文關鍵詞： magnetic resonance imaging, breast cancer, computer 
aided detection 
 
中文摘要及關鍵詞 
 
  對於乳房磁振造影（MRI）而言，因為在顯影劑的幫助下病灶容易被顯影強化，MRI是
最適合用來偵測乳癌的工具。不同於 X光和 CT, MRI 沒有游離輻射且對人體不具侵襲性，
可以提供詳細的三度空間影像，而且可以利用高對比的特性去將不同組織的特性呈現出
來，是現代醫學不可或缺的診斷工具。不僅僅是解剖的影像，更重要的是組織的功能性或
是代謝的性質會被顯示出來。因此近年來， MRI被用於許多臨床的診斷，例如腦部病變和
乳房腫瘤，但由於動態顯影 MRI所產生之大影像資訊，使用電腦輔助（computer aided）
技術來偵測及評估具有大量影像之乳房 MRI檢查，可以減少影像檢查之判讀時間和因為經
驗不足而導致的誤判，更重要的是可以增加診斷正確性及敏感度。 
  在前兩年的研究中我們成功的使用動態曲線和型態的特徵去正確診斷腫瘤，但是我們
認為如果結合兩者來做診斷的話，應該可以互相補足另一種特徵的缺點，進而提高診斷的
準確率。本研究計畫在第三年中，則藉由顯影的變化和腫瘤的型態上的特徵合併，發展一
個能夠診斷乳房病灶，並可評估其功能特性之有效的電腦輔助系統。 
  在過去三年計劃中，我們完成下列項目，(1) 切割腫瘤的區域 (2) 使用 fuzzy C mean
技術應用於動力曲線 (kinetic curve) 特徵之選擇與分析，(3) 不同乳房病灶形態特徵方法
之探討，(4) 局部乳房病灶之特徵擷取及特性分析（feature extraction and characterization）
方法之設定，(5)藉由臨床試驗蒐集病患乳房磁振造影資料，(6) 合併顯影的變化和腫瘤的
型態上的特徵。本研究之初步成果顯示，利用動態曲線和型態的特徵所建置之電腦輔助系
統是可以增加診斷效益，未來我們將持續建立乳房磁振造影影像分析系統架構，並將推展
到臨床應用。 
 
 
 
 
關鍵字：磁振造影、乳癌、電腦輔助偵測 
報告內容： 
 
前言與文獻探討 
 
  依據行政院衛生署民國 99年報告，乳癌佔為全國十大癌症之第四名，佔女性癌症死亡
原因為第四位，每年約有 1,700 名女性因乳癌而死亡。乳癌是女性在世界中最常罹患的癌
症，而也是女性的主要死因之一。如果能早期發現有類似的症狀發生，就有較高的機會能
夠完全治癒。因此，乳癌之診斷與治療為重要課題。近年來，電腦的輔助診斷
（computer-assisted diagnosis）不只提供了腫瘤大小、位置的資訊，甚至能進一步的分
辨出腫瘤的良惡性。動態對比增強的核磁共振影像用來紀錄顯影劑隨著時間的變化的成
像。在此提出一個新的切割腫瘤方法，利用動力學彩色圖與曲線下面積彩色圖所結合成的
彩色圖找出腫瘤並加以切割，再利用兩類不同的特徵，各別為動力曲線、三維型態分析，
來描述分析腫瘤的良惡性。利用改良的 fuzzy C-means 方式找出能代表這個腫瘤的動力曲
線，接著使用 Tofts 動力曲線模型來分析找出的動力曲線，其模型所得的參數為其動力曲
線之特徵。此外，三維型態分析包涵了形狀及材質的特徵，而形狀分析有緊實度、邊緣的
變化以及與所對應的橢圓模型比對的結果作為三維形狀上的特徵。還有材質的特徵使用了
灰階值共生矩陣對腫瘤進行紋理的分析。上述三種特徵為腫瘤良惡性判斷的依據，提供作
為實驗統計上的資料。在這個實驗中，總計 132 個病理檢驗過的腫瘤作為實驗資料，其中
包涵 63 個良性、69 個惡性的病例。乳房磁振造影（magnetic resonance imaging，簡稱
MRI）是目前公認最敏感偵測乳癌的工具 [1-6]。乳房 MRI 有許多臨床應用價值[1-8]，包
括可以偵測到 X 光乳房攝影及超音波所無法顯現之病灶、更準確的評估腫瘤之特性、手術
後殘餘乳癌之偵測、新輔助性化學治療（neoadjuvant chemotherapy）之評估[9-12]。因
此乳房 MRI之臨床使用也愈來愈普及。 
在此三年的研究中，我們使用了乳房 MRI之動態對比劑顯影（dynamic contrast 
enhancement, DCE）可提供動力學（kinetic）訊息，可以增加區分良惡性診斷之正確率[10],
可以藉由被顯影程度的不同來判斷病灶。一般乳房 MRI之判讀為以型態為主，如要加上動
態顯影（DCE）MRI之動力學時間訊號曲線之訊息，在臨床上必須由醫師手動圈選幾個點來
觀察顯影的變化，結合兩種特徵則有助於良惡性之區別 [8-10]。而在我們的研究中，我們
能自動的找出腫瘤內部最有代表性的點，利用此點的特徵來診斷腫瘤。 
由動態對比劑顯影 DCE MRI可以獲得不同時間點顯影影像，以及每個像素之時間訊號
kinetic color map, there are two time points used, the precontrast and the maximal enhanced time 
points. The maximum enhancement ratio (Emax) of a kinetic curve is defined by: 
0
0max
max S
SSE −=                          (Eq. 1) 
where Smax is the maximum enhanced intensity, and S0 is the preconstast intensity. In general, 
malignant lesions has a tendency towards relating Emax more than 100% in early phase . Hence, 
the thresholds we used for different colors are 200%, 100%, and 50%. The yellow color 
represents Emax larger than 200%, the red color represents Emax larger than 100% but fewer than or 
equal to 200%, the blue color represents Emax larger than 50% but fewer than or equal to 100%, 
and no color represents otherwise. 
The proposed AUC color map provides the greater cumulated signal intensity of kinetic 
curves over time. The AUC value means the measure of area under the kinetic curve and is 
obtained by the integration of the kinetic curve intensity from the initial to the end of study time. 
It could be defined by 
∫= dttIAUC )(                            (Eq. 2) 
where I(t) is the kinetic curve intensity on time t. Because the voxels of the breast tumor has 
greater AUC values, the AUC map is painted by three different colors (red, yellow, and blue) to 
represent different ranges of AUC values for indicating the tumor. The red color represents the 
AUC larger than or equal to 90% in the cumulative histogram of AUC, the yellow color represent 
the AUC larger than 80% but fewer than 90%, and the blue color represent the AUC larger than 
60% but fewer than 80%, and no color represents otherwise. 
Tumors after injecting a contrast agent will have greater maximum enhancement and greater 
AUC values than the general tissue in the breast. Combining the property of the above two color 
maps obtains the integrated color map. The integrated color map is painted by three different 
colors (purple, red, and yellow). The purple color represents yellow in the kinetic color map and 
red in the AUC color map on the same voxel, the red color represents only red in the AUC color 
map on the voxel, the yellow color represents only yellow in the kinetic color map on the voxel, 
and no color represents otherwise. 
In this study, the 3-D DCE-MRI image size is 256 × 256 × n, where n is the total slice 
 
Fig. 1 The process of tumor segmentation. 
Combination 
Seed & VOI specification 
Region growing segmentation 
Tumor extraction 
 
Kinetic color map AUC color map 
Integrated color map 
Integrated color map with 
seed & VOI 
Tumor-of-interest image Source images 
Segmented tumor 
 Fig. 2 Selection of a representative kinetic curve in the invasive ductal carcinoma using fuzzy 
C-means (FCM) clustering technique. (a) a segmented breast tumor marked with three 
points (A, B, and C) for kinetic curve analysis. (b) three different types of kinetic curve 
with different points in the breast tumor (c) The representative kinetic curve identified by 
the FCM clustering shows characteristic rapid slope and wash-out pattern suggestive of 
malignancy. 
R
el
at
iv
e 
en
ha
nc
em
en
t 
Time (sec) 
0 480 
1.5 
2.0 
2.5 
3.0 
1.0 
Point A: type III 
Point B: type II 
Point C: type I 
(b) 
R
el
at
iv
e 
en
ha
nc
em
en
t 
Time (sec) 
0 480 
1.5 
2.0 
2.5 
3.0 
1.0 
FCM 
 
(c) 
B 
A 
C 
(a) 
 Fig. 3 Spatial distribution of a particular voxel (gray) and its corresponding 26 neighboring pixels 
(dark). 
 
The set of texture-based features extracted from these GLCMs are defined as follows: 
(1) Energy: ( )21
,
,
i j
G g i j= ∑          (Eq. 5) 
(2) Entropy: ( ) ( )2 2
,
, log ,
i j
G g i j g i j= −∑       (Eq. 6) 
(3) Correlation: 
( ) ( ) ( )
,
3 2
,
i j
i j g i j
G
µ µ
σ
− −
=
∑
     (Eq. 7) 
(4) Difference Moment: 
( )
( )4 2
,
1 ,
1i j
G g i j
i j
=
+ −
∑     (Eq. 8) 
(5) Inertia: ( ) ( )25
,
,
i j
G i j g i j= −∑        (Eq. 9) 
(6) Cluster Shade: ( ) ( ) ( )36
,
,
i j
G i j g i jµ µ= − + −  ∑     (Eq. 10) 
y 
x 
z 
( ) ( ) ( )2 2 21 c c c
ib
x j boundary
k
R i x j y k z
n  
 = ∈
 
 
= − + − + −∑    (Eq. 16) 
( )2
1
x
x boundary
s
b
R R
R
n
∈
−
=
−
∑
        (Eq. 17) 
where nb is the number of the boundary voxels and x is the boundary voxel. 
 
Ellipsoid Fitting Features 
Elliptic model is usually used to describe an arbitrary shape even though the shape is unlike 
an ellipsoid. In this paper, the fitting elliptic model is defined by minimized the distance 
between the tumor and the model in R3 space , illustrated as Fig. 4. 
The surface area of the fitting ellipsoid (Ae) used in this study is given by Knud Thomsen's 
formula, which is broadly used in many papers, such as: 
1
1 2 2 3 3 14
3
p p p p p p p
e
L L L L L LA π  + +=  
 
    (Eq. 18) 
where p = 1.6075 yields a relative error of at most 1.061%. Several useful 2-D elliptic features 
proposed by Shen et al. are extended in the 3-D form in this study. The axis ratio ERaxis, which 
measures the flat degree of the ellipsoid, is defined as  
{ }
{ }
1 2 3
1 2 3
max , ,
min , ,axis
L L L
ER
L L L
=      (Eq. 19) 
The surface ratio ERsurface means the ratio of the surface area between the tumor (A) and the 
fitting model (Ae), it could be defined by  
surface
e
AER
A
=        (Eq. 20) 
The volume covering ratio ERand means the ratio of the intersection of the ellipsoid and the 
tumor and the volume of the tumor (V), it could be defined by  
( )m e
and
volume v vER
V
∩
=     (Eq. 21) 
where vm is the voxels set of the real mass, ve is the voxels set of the ellipsoid, and ∩ denotes the 
intersection of the above two sets. 
direction of the axes in the ellipsoid and the intersection of these three vectors is the center 
of the ellipsoid. 
 
Fig. 5 The illustrated plot of ellipsoid fitting features, outside regions and inside regions. The 
outside regions are counted into the variable ENout and the inside regions are counted into 
the variable ENin. 
 
Fig. 6 The illustrated plot of ellipsoid fitting features, outside ratio and inside ratio. The outside 
ratio is estimated by a/b and the inside one is c/d. a is the distance of an outside contour 
point and b is the one of corresponding elliptic point from the tumor center. c is the 
distance of an inside contour point and d is the one of corresponding elliptic point from 
the tumor center. 
b 
d 
Center of the ellipsoid 
c 
a 
Outside angularity 
Inside angularity 
Outside region 
Inside region 
 Table 1 Features of four categories are used in this study. 
Features 
Description 
Category Symbol 
Conventional kinetic curve characteristics 
Fk1 Maximum enhancement 
Fk2 Time to peak 
Fk3 Uptake rate 
Fk4 Washout rate 
Tofts model 
Ktrans 
Volume transfer constant between 
plasma and EES 
kep 
Rate constant 
between plasma and EES 
vp Volume of plasma 
ve Volume of EES 
Texture 
G1 Energy 
G2 Entropy 
G3 Correlation 
G4 Inverse difference moment 
G5 Inertia 
G6 Cluster shade 
G7 Cluster prominence 
G8 Haralick’s correlation 
Shape 
C1 Conventional compactness 
C2 New compactness 
R Radius 
Rs Speculation 
ERaxis Axis ratio 
ERsurface Surface ratio 
ERand Volume covering ratio 
ENin Number of the inside regions 
ENout Number of the outside regions 
ENio Sum of ENin and ENout 
ENa_in 
Number of inside 
angular regions 
ENa_out 
Number of the outside 
angular regions 
ENa_io Sum of ENa_in and ENa_out 
Eangle Orientation 
 
 Table 2 The selected features of each category. 
 
Method 
Conventional 
kinetic 
characteristics 
Tofts model GLCM Shape All 
Selected 
Features 
Fk1 
Fk2 
Fk3 
Fk4 
kep 
vp 
G1 
G2 
G4 
G8 
C2 
R 
ERand 
ENin 
ENa_in 
kep 
vp 
G1 
G2 
C2 
 
 
Table 3  The performance indexes of conventional kinetic characteristics, Tofts model, GLCM, 
shape, and all the proposed features. 
 
Method 
Item 
Conventional 
kinetic 
characteristics 
Tofts model GLCM Shape All 
Accuracy (%) 84.85 (112/132) 
86.36 
(114/132) 
81.82 
(108/132) 
80.30 
(106/132) 
91.67 
(121/132) 
Sensitivity (%) 79.71 (55/69) 
85.51 
(59/69) 
81.16 
(56/69) 
78.26 
(54/69) 
91.30 
(63/69) 
Specificity (%) 90.48 (57/63) 
87.30 
(55/63) 
82.54 
(52/63) 
82.54 
(52/63) 
92.06 
(58/63) 
PPV (%) 90.16 (55/61) 
88.06 
(59/67) 
83.58 
(56/67) 
83.08 
(54/66) 
92.65 
(63/68) 
NPV (%) 80.28 (57/71) 
84.62 
(55/65) 
80.00 
(52/65) 
77.61 
(52/66) 
90.63 
(58/64) 
 
Note: 
Accuracy = (TP+TN) / (TP+TN+FP+FN) 
Sensitivity = TP / (TP+FN) 
Specificity = TN / (TN+FP) 
Positive Predictive Value = TP / (TP+FP) 
Negative Predictive Value = TN / (TN+FN) 
 
Summary: 
In this DCE-MRI computer-aided diagnosis system, an integrated color map combining the 
kinetic color map and the AUC color map is used to help the user to indicate the lesion and a 
region growing method is used to segment the tumor for diagnosis. In order to identify the 
representative kinetic curve for the tumor, the modified fuzzy c-means clustering with maximum 
initial enhancement is adopted for improving the diagnosis performance. The modified method 
could select the kinetic curve with higher possibility of malignance. Four categories of features, 
conventional kinetic characteristics, Tofts model, texture, and shape, are proposed to diagnosis 
the tumor based on the kinetic and morphology information. The morphology information could 
much improve the performance of the kinetic information. Furthermore, based on the property 
of the color map, the chosen lesion is a mass with larger enhanced or cumulative intensity than 
that of surrounding tissues. Therefore, if there is a necrotic tissue inside the lesion, it will cause 
a hole in the lesion and the hole is not marked in the color map. The situation might affect the 
performance of ellipse fitting features. 
Besides, patient movement often occurs during the dynamic MRI scan in the clinical 
experiences, the proposed system is worth to add the image registration to further improve the 
diagnosis accuracy. In the future, the higher resolution MRI images could be used to improve 
the performance of morphology features. Combining the improved morphology features with 
the Tofts kinetic features should provide a CAD system with high accuracy.  
 
for detection and characterization of breast lesions: preliminary evaluation of a new 
software for MR-based breast imaging. Internal Congress Series 
2005;1281:1081-1086. 
17. Chen W, Giger ML, Bick U, Newstead GM. Automatic identification and classification 
of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys 
2006;33(8):2878-2887. 
18. Lehman CD, Peacock S, DeMartini WB, Chen X. A new automatic software system to 
evaluate breast MR examinations: improved specificity without decreased sensitivity. 
AJR Am J Roentgenol 2006;187:51-56 
19. Cardillo FA, Starita A, Caramella D, Cilotti A. A tool for breast MR images    
processing and classification. Proceedings of the 2002 IEEEE, page 181-184. 
20. Wang H, Huo Z, Zhang J. Computerized classification method for differentiating 
between benign and malignant lesions on breast MR images. Proceedings of the 
2005 IEEE, page 6950-6952. 
21. Tzacheva AA, Najarian K, Brockway JP. Breast cancer detection in 
gadolinium-enhanced MR images by static region descriptors and neural networks. J 
Magn Reson Imag 2003;17:337-342.  
97 年度專題研究計畫研究成果彙整表 
計畫主持人：張允中 計畫編號：97-2221-E-002-166-MY3 
計畫名稱：乳房磁振造影電腦輔助偵測與功能性評估系統之研發 
量化 
成果項目 實際已達成
數（被接受
或已發表）
預期總達成
數(含實際已
達成數) 
本計畫實
際貢獻百
分比 
單位 
備 註 （ 質 化 說
明：如數個計畫
共同成果、成果
列 為 該 期 刊 之
封 面 故 事 ...
等） 
期刊論文 0 0 100%  
研究報告/技術報告 0 0 100%  
研討會論文 0 0 100% 
篇 
 
論文著作 
專書 0 0 100%   
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 0 0 100%  
博士生 0 0 100%  
博士後研究員 0 0 100%  
國內 
參與計畫人力 
（本國籍） 
專任助理 0 0 100% 
人次 
 
期刊論文 0 0 100%  
研究報告/技術報告 0 0 100%  
研討會論文 0 0 100% 
篇 
 
論文著作 
專書 0 0 100% 章/本  
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 0 0 100%  
博士生 0 0 100%  
博士後研究員 0 0 100%  
國外 
參與計畫人力 
（外國籍） 
專任助理 0 0 100% 
人次 
 
